• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对包括骨活检在内的双膦酸盐相关颌骨坏死病例手术治疗的易感因素及相关结果进行评估。

Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies.

作者信息

Kim Tae-Hwan, Seo Won-Gyo, Koo Chul-Hong, Lee Jae-Hoon

机构信息

Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, Cheonan, Korea.

出版信息

J Korean Assoc Oral Maxillofac Surg. 2016 Aug;42(4):193-204. doi: 10.5125/jkaoms.2016.42.4.193. Epub 2016 Aug 24.

DOI:10.5125/jkaoms.2016.42.4.193
PMID:27595086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5009193/
Abstract

OBJECTIVES

This study examined the statistical relevance of whether the systemic predisposing factors affect the prognosis of surgical treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ). All cases had undergone bone biopsies to determine the characteristics of the mechanisms of BRONJ by optical microscopy.

MATERIALS AND METHODS

The data included 54 BRONJ cases who underwent surgery and in whom bone biopsies were performed. The results of surgery were evaluated and the results were classified into 3 categories: normal recovery, delayed recovery, and recurrence after surgery. The medical history, such as diabetes mellitus, medication of steroids, malignancies on other sites was investigated for an evaluation of the systemic predisposing factors in relation to the prognosis. The three factors involved with the medication of bisphosphonate (BP) were the medication route, medication period, and drug holiday of BP before surgery. The serum C-terminal cross-linking telopeptide (CTX) value and presence of microorganism colony in bone biopsy specimens were also checked. Statistical analysis was then carried out to determine the relationship between these factors and the results of surgery.

RESULTS

The group of patients suffering from diabetes and on steroids tended to show poorer results after surgery. Parenteral medication of BP made the patients have a poorer prognosis after surgery than oral medication. In contrast, the medication period and drug holiday of BP before surgery did not have significance with the results of surgery nor did the serum CTX value and presence of microorganism colony. Necrotic bone specimens in this study typically showed disappearing new bone formation around the osteocytic lacunae and destroyed Howship's lacunae.

CONCLUSION

Although many variables exist, this study could in part, predict the prognosis of surgical treatment of BRONJ by taking the patient's medical history.

摘要

目的

本研究探讨全身易感因素是否影响双膦酸盐相关颌骨骨坏死(BRONJ)手术治疗预后的统计学相关性。所有病例均进行了骨活检,以通过光学显微镜确定BRONJ的机制特征。

材料与方法

数据包括54例接受手术并进行了骨活检的BRONJ病例。评估手术结果并将结果分为3类:正常恢复、恢复延迟和术后复发。调查病史,如糖尿病、类固醇药物使用情况、其他部位的恶性肿瘤,以评估与预后相关的全身易感因素。与双膦酸盐(BP)用药相关的三个因素是BP的用药途径、用药时间和术前停药期。还检查了血清C端交联端肽(CTX)值和骨活检标本中微生物菌落的存在情况。然后进行统计分析以确定这些因素与手术结果之间的关系。

结果

患有糖尿病且使用类固醇的患者组术后结果往往较差。BP的胃肠外给药使患者术后预后比口服给药差。相比之下,术前BP的用药时间和停药期与手术结果无关,血清CTX值和微生物菌落的存在情况也无关。本研究中的坏死骨标本通常显示骨陷窝周围新骨形成消失,Howship陷窝破坏。

结论

尽管存在许多变量,但本研究可以通过了解患者病史部分预测BRONJ手术治疗的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/1b4f01a76507/jkaoms-42-193-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/65636900ebdd/jkaoms-42-193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/412216ddcb86/jkaoms-42-193-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/3d39234325fe/jkaoms-42-193-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/e5986da040cf/jkaoms-42-193-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/1b4f01a76507/jkaoms-42-193-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/65636900ebdd/jkaoms-42-193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/412216ddcb86/jkaoms-42-193-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/3d39234325fe/jkaoms-42-193-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/e5986da040cf/jkaoms-42-193-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64cd/5009193/1b4f01a76507/jkaoms-42-193-g005.jpg

相似文献

1
Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies.对包括骨活检在内的双膦酸盐相关颌骨坏死病例手术治疗的易感因素及相关结果进行评估。
J Korean Assoc Oral Maxillofac Surg. 2016 Aug;42(4):193-204. doi: 10.5125/jkaoms.2016.42.4.193. Epub 2016 Aug 24.
2
The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.手术切除在双膦酸盐相关颌骨骨坏死治疗中的作用。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006.
3
Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers.预测双膦酸盐相关颌骨坏死的风险:I型胶原C端肽与影像学标志物的比较
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):509-16. doi: 10.1016/j.tripleo.2010.04.023. Epub 2010 Jul 31.
4
Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.用于预测接受双膦酸盐治疗患者颌骨坏死发生情况的血清学骨标志物。
J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.
5
Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.双膦酸盐相关颌骨坏死(BRONJ)的治疗。一项批判性综述。
Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13.
6
Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.考虑原发性疾病和伴随治疗时双膦酸盐相关性颌骨骨坏死的发生率。
Anticancer Res. 2013 Sep;33(9):3917-24.
7
Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates.接受双膦酸盐治疗的颌骨骨坏死患者的前瞻性生物标志物评估。
Bone. 2013 Nov;57(1):201-5. doi: 10.1016/j.bone.2013.08.005. Epub 2013 Aug 14.
8
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.
9
Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.双膦酸盐治疗患者中与牙种植体相关的骨坏死
Clin Oral Implants Res. 2014 May;25(5):632-40. doi: 10.1111/clr.12088. Epub 2012 Dec 26.
10
Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients.数据库分析匈牙利患者双膦酸盐相关性颌骨坏死的风险因素。
BMJ Open. 2019 May 22;9(5):e025600. doi: 10.1136/bmjopen-2018-025600.

引用本文的文献

1
Application of navigation system during surgery for medication-related osteonecrosis of the jaw.导航系统在颌骨药物性骨坏死手术中的应用。
J Korean Assoc Oral Maxillofac Surg. 2025 Jun 30;51(3):174-179. doi: 10.5125/jkaoms.2025.51.3.174.
2
Prognostic indicators in medication-related osteonecrosis of the jaw: A systematic review and meta-analysis.颌骨药物相关性骨坏死的预后指标:一项系统评价和荟萃分析。
Osteoporos Int. 2025 Mar 24. doi: 10.1007/s00198-025-07464-7.
3
Magnesium Nanocomposite Hydrogel Reverses the Pathologies to Enhance Mandible Regeneration.

本文引用的文献

1
Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long-term results.双膦酸盐相关骨坏死的外科治疗:预后评分及长期结果
J Craniomaxillofac Surg. 2015 Nov;43(9):1809-22. doi: 10.1016/j.jcms.2015.07.035. Epub 2015 Aug 6.
2
Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.双膦酸盐相关颌骨坏死的外科治疗:单一机构的六年经验
J Oral Maxillofac Surg. 2015 Jul;73(7):1288-95. doi: 10.1016/j.joms.2015.01.008. Epub 2015 Jan 22.
3
Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary.
镁纳米复合水凝胶逆转病理状态以促进下颌骨再生。
Adv Mater. 2025 Jan;37(2):e2312920. doi: 10.1002/adma.202312920. Epub 2024 Oct 10.
4
Prediction of wound healing status following dental extraction using Adapted-University of Connecticut osteonecrosis numerical scale: A retrospective study.使用改良的康涅狄格大学骨坏死数值量表预测拔牙后伤口愈合状况:一项回顾性研究。
Health Sci Rep. 2024 Jun 24;7(6):e2184. doi: 10.1002/hsr2.2184. eCollection 2024 Jun.
5
Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis.药物停用对骨质疏松症患者颌骨药物相关性骨坏死的临床意义。
J Korean Assoc Oral Maxillofac Surg. 2023 Apr 30;49(2):75-85. doi: 10.5125/jkaoms.2023.49.2.75.
6
Comparison of the Effect of Oral Versus Intravenous Bisphosphonate Administration on Osteoclastogenesis in Advanced-Stage Medication-Related Osteonecrosis of the Jaw Patients.口服与静脉注射双膦酸盐给药对晚期药物相关性颌骨坏死患者破骨细胞生成影响的比较
J Clin Med. 2021 Jul 4;10(13):2988. doi: 10.3390/jcm10132988.
7
Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review.颌骨骨坏死相关双膦酸盐个体的临床特征:综合回顾。
Sao Paulo Med J. 2020 Jul-Aug;138(4):326-335. doi: 10.1590/1516-3180.2019.0352.r2.15052020.
8
Risk factors of medication-related osteonecrosis of the jaw: a retrospective study in a Turkish subpopulation.药物相关性颌骨坏死的危险因素:一项针对土耳其亚人群的回顾性研究。
J Korean Assoc Oral Maxillofac Surg. 2019 Apr;45(2):108-115. doi: 10.5125/jkaoms.2019.45.2.108. Epub 2019 Apr 29.
9
Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review.药物相关性颌骨骨坏死的治疗结果和预后因素:基于病例和文献的回顾。
Clin Oral Investig. 2019 Aug;23(8):3203-3211. doi: 10.1007/s00784-018-2743-0. Epub 2018 Nov 8.
双膦酸盐相关颌骨骨坏死是一种感染吗?一项组织学和微生物学的十年总结。
Int J Dent. 2014;2014:452737. doi: 10.1155/2014/452737. Epub 2014 Jun 24.
4
Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis.服用双膦酸盐预防骨质疏松症患者的骨坏死风险:一项系统评价和荟萃分析。
Osteoporos Int. 2014 Mar;25(3):1131-9. doi: 10.1007/s00198-013-2575-3. Epub 2013 Dec 17.
5
Diabetes microvascular disease and the risk for bisphosphonate-related osteonecrosis of the jaw: a single center study.糖尿病微血管病变与双膦酸盐相关性颌骨骨坏死风险:一项单中心研究。
J Clin Endocrinol Metab. 2013 Nov;98(11):E1807-12. doi: 10.1210/jc.2013-2434. Epub 2013 Sep 13.
6
The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw--results of a clinical case series with an average follow-up of 20 months.双膦酸盐相关颌骨坏死的手术治疗结果——平均随访20个月的临床病例系列结果
Clin Oral Investig. 2014 May;18(4):1299-1304. doi: 10.1007/s00784-013-1092-2. Epub 2013 Aug 29.
7
Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis.双膦酸盐相关性颌骨坏死:临床病理研究与组织形态计量分析。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 May;115(5):660-6. doi: 10.1016/j.oooo.2013.03.001.
8
Pamidronate enhances bacterial adhesion to bone hydroxyapatite. Another puzzle in the pathology of bisphosphonate-related osteonecrosis of the jaw?帕米膦酸盐增强细菌对骨羟基磷灰石的黏附。这是双膦酸盐相关颌骨坏死病理学中的另一个谜团?
J Oral Maxillofac Surg. 2013 Jun;71(6):1010-6. doi: 10.1016/j.joms.2012.12.005. Epub 2013 Mar 13.
9
Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy.应用宏基因组学技术研究与双膦酸盐治疗相关的颌骨骨坏死患者的微生物和病毒。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Dec;114(6):764-70. doi: 10.1016/j.oooo.2012.08.444.
10
Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients.静脉注射双膦酸盐相关性下颌骨坏死:109 例患者的长期随访。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Feb;115(2):192-200. doi: 10.1016/j.oooo.2012.05.017. Epub 2012 Oct 1.